How common is persistent itching in graft-versus-host disease?

Graft-versus-host disease can affect the skin after a donor stem-cell transplant, and itch may occur with rash, redness, dryness, scaling, or skin tightness. “Common” refers to people who have graft-versus-host disease; it does not determine why a particular person is itchy.

After a transplant, itchy skin can also relate to dry skin, medicines, contact reactions, infection, or other changes. Your transplant team knows your treatment history and can judge whether the timing and skin findings need evaluation.

Tell your transplant team about new or continuing itch rather than waiting for a routine visit. Record when it began, where it occurs, whether a rash is present, and any new medicines, detergents, or skin products. Clear photographs can help show changes that come and go.

Keep the skin gently moisturised with products your team has approved, and avoid hot baths or fragranced products if they aggravate irritation. Do not change transplant medicines, including immune-suppressing treatment, unless your treating team tells you to do so.

Contact the transplant team urgently for a rapidly spreading rash, blisters, peeling skin, painful skin, fever, or signs of infection such as warmth, pus, or increasing tenderness. Seek emergency help for breathing difficulty or swelling of the face, lips, or tongue.

Could this be related to graft-versus-host disease, a medicine, or another skin problem? What skin changes need same-day contact? Which moisturisers or anti-itch treatments fit safely with my transplant care plan?